Patent Refused for AIDS Drug

by Rajashri on  September 3, 2009 at 10:43 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

 Patent Refused for AIDS Drug
Tenofovir, an anti-AIDS medicine manufactured by Gilead Sciences was refused patent protection by the Indian patent office. The patent was refused as pre-grant opposition had told authorities that the application did not take any "inventive steps and failed to satisfy the patentability criteria under Indian rules."

Tenofovir happens to be an important drug against AIDS and has been recommended by the WHO as a primary medicine to fight off the virus.

In an unprecedented move Brazilian AIDS advocacy group Brazilian Interdisciplinary AIDS Association (ABIA) joined hands with India's Centre for Residential Care and Rehabilitation (SAHARA) in opposing the patent.

Industry sources say Gilead is likely to appeal against the decision.


Source: Medindia
RAS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs AIDS - Initial Theories and Disease Progression 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive